Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-1-26
|
pubmed:abstractText |
Platelet MAO-B levels have been investigated in seventeen consecutively diagnosed and previously untreated patients with idiopathic Parkinson's disease using the non-hydroxylated catecholamine, beta-phenylethylamine, as substrate. Patients with Parkinson's disease had MAO-B activity levels that were considerably higher than sex and age matched normal controls or patients with Motor neurone disease or Myasthenia gravis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0936-3076
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2597311-Adult,
pubmed-meshheading:2597311-Aged,
pubmed-meshheading:2597311-Blood Platelets,
pubmed-meshheading:2597311-Female,
pubmed-meshheading:2597311-Humans,
pubmed-meshheading:2597311-Male,
pubmed-meshheading:2597311-Middle Aged,
pubmed-meshheading:2597311-Monoamine Oxidase,
pubmed-meshheading:2597311-Parkinson Disease, Secondary
|
pubmed:year |
1989
|
pubmed:articleTitle |
Platelet monoamine oxidase-B activity in Parkinson's disease.
|
pubmed:affiliation |
Department of Neurology, Queen Elizabeth Medical Centre, Birmingham, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|